Subscribe To
Krystal biotech: a buy for growth potential
Children suffering dystrophic epidermolysis bullosa (DEB), a serious genetic disease, are affectionately called butterfly children, depicting their fr...
November 6, 2022, 1:40 am
Trinity biotech plc (trib) q2 2022 earnings call transcript
Trinity biotech plc (NASDAQ:TRIB ) Q2 2022 Results Conference Call November 3, 2022 11:00 AM ET Company...
November 5, 2022, 12:52 pm
Why macrogenics stock blasted higher today
A quarter that was far better than expected gets investors excited about the biotech at the end of the ...
November 4, 2022, 6:51 pm
Biontech stock surges toward 3-month high after report china agrees to approve its covid vaccine for foreigners
Shares of Germany-based BioNTech SE BNTX, +2.64% surged 5.1% toward a three-month high in premarket trading Friday, after The Wall Street Journal repo...
November 4, 2022, 6:23 am
Adaptive biotechnologies corporation (adpt) q3 2022 earnings call transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Karina Calzadill...
November 3, 2022, 10:36 pm
Vir biotechnology, inc. (vir) q3 earnings and revenues surpass estimates
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 12,900% and 143.56%, respectively, for the quarter ended September 2022. Do ...
November 3, 2022, 7:35 pm
biotech stock catalyst pharmaceuticals offers buy point ahead of earnings
Catalyst Pharmaceuticals approaches a buy point with earnings due. Stellar ratings support the price action....
November 3, 2022, 2:26 pm
Vyant bio sells biotech branch vivopharm to reaction biology for $5.5 million
Vyant Bio (NASDAQ:VYNT) Inc said it has closed a definitive agreement with Reaction Biology Corporation in the sale of its subsidiary vivoPharm LLC, a...
November 3, 2022, 11:06 am
Celcuity inc. schedules release of third quarter 2022 financial results and webcast/conference call
MINNEAPOLIS, MN/ ACCESSWIRE / November 3, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targete...
November 3, 2022, 8:50 am
Virios therapeutics to report third quarter 2022 financial results and provide corporate update on monday, november 14, 2022
ATLANTA--(BUSINESS WIRE)---- $VIRI #Biotech--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing ...
November 3, 2022, 7:05 am
The sell rating of labd is reaffirmed
Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology se...
November 3, 2022, 3:36 am
Best stocks to buy now? 4 biotech stocks in focus
Is now a good time to add these biotech stocks to your watchlist?...
September 11, 2022, 12:10 pm
Bavarian nordic a/s could post a strong comeback
Bearish sentiment weighed heavily on the biotech industry and Bavarian Nordic A/S. There is reason for ...
September 11, 2022, 8:41 am
Does a revolutionary new als drug make this biotech stock a buy now?
The FDA will most likely approve this company's first drug, but what comes next is more difficult to predict....
September 11, 2022, 5:41 am
3 growth stocks that are crushing it this year
These three biotech companies have bucked the trend of declining shares prices in their sector....
September 10, 2022, 10:45 am
Charles river laboratories: a 'picks and shovels' biomedical play, now attractively priced
Charles River Labs, or "CRL", provides critical discovery, clinical and safety services to nearly all biotech ...
September 10, 2022, 1:56 am
Atreca to present at upcoming investor conferences
SAN CARLOS, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on develop...
September 9, 2022, 4:05 pm
3d systems ($ddd) forms systemic bio to accelerate drug discovery and development
3D Systems ($DDD) has announced the formation of a new wholly owned company named Systemic Bio. The new biotec...
September 9, 2022, 11:29 am
Why regeneron pharmaceuticals stock is crushing it today
The biotech's crown jewel scores a key win in the clinic....
September 8, 2022, 2:32 pm
Small pharma to participate in upcoming september investor conferences
LONDON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology com...
September 8, 2022, 12:24 pm